Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsReceivablesReceivables - NetShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sanofi (SNY) Inventory (2016 - 2024)

Historic Inventory for Sanofi (SNY) over the last 17 years, with Q2 2025 value amounting to $10.9 billion.

  • Sanofi's Inventory fell 470.48% to $10.9 billion in Q2 2025 from the same period last year, while for Jun 2025 it was $10.9 billion, marking a year-over-year decrease of 470.48%. This contributed to the annual value of $10.1 billion for FY2024, which is 361.48% down from last year.
  • Latest data reveals that Sanofi reported Inventory of $10.9 billion as of Q2 2025, which was down 470.48% from $10.1 billion recorded in Q4 2024.
  • In the past 5 years, Sanofi's Inventory registered a high of $11.4 billion during Q2 2024, and its lowest value of $9.1 billion during Q4 2022.
  • In the last 5 years, Sanofi's Inventory had a median value of $10.4 billion in 2023 and averaged $10.4 billion.
  • As far as peak fluctuations go, Sanofi's Inventory soared by 1383.28% in 2021, and later tumbled by 1038.94% in 2022.
  • Sanofi's Inventory (Quarter) stood at $10.0 billion in 2021, then fell by 8.31% to $9.1 billion in 2022, then grew by 13.77% to $10.4 billion in 2023, then fell by 3.1% to $10.1 billion in 2024, then grew by 8.03% to $10.9 billion in 2025.
  • Its Inventory was $10.9 billion in Q2 2025, compared to $10.1 billion in Q4 2024 and $11.4 billion in Q2 2024.